MedTrace Logo

Community Screening Study of Diabetic Retinopathy in Tianjin in 2024

NCT06478407 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 18000

Last updated 2024-07-10

No results posted yet for this study

Summary

Through this study, the investigators hope to understand the prevalence and influencing factors of diabetic retinopathy in Tianjin, improve the ability of complication detection and intervention in diabetic patients in primary medical and health institutions, and build a diabetes prevention and treatment network. The investigators should adhere to the policy of prevention first, combined with prevention and control, and explore a diabetes' prevention and control model suitable for our city. Extensive publicity and education should be carried out to improve the awareness of self-management ，improve the screening rate of diabetic retinopathy, and reduce the blindness rate.

Conditions

Sponsors & Collaborators

  • Tianjin Medical University Eye Hospital

    collaborator OTHER

  • Li Xiaorong

    lead OTHER

Principal Investigators

  • Xiaorong Li, professor · Tianjin Medical University Eye Hospital

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-28
Primary Completion
2025-03-28
Completion
2025-03-28

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06478407 on ClinicalTrials.gov